Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis

This study has been completed.
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00461721
First received: April 17, 2007
Last updated: December 2, 2015
Last verified: December 2015
  Purpose
To find a test to elaborate a parameter for specific immunotherapy in allergic patients

Condition Phase
Allergy
Phase 1

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis Due to Grass Pollen During Immunotherapy

Further study details as provided by University of Zurich:

Estimated Enrollment: 20
Study Start Date: December 2006
Study Completion Date: December 2008
Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
x
Criteria

Inclusion Criteria:

  • Age between 18 and 65
  • Signed informed consent
  • SIT 2000/2001
  • 10 patients with SIT with a good result- 10 patients with bad results

Exclusion criteria:

  • Pregnancy and breastfeeding
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00461721

Locations
Switzerland
Department of Dermatology
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

ClinicalTrials.gov Identifier: NCT00461721     History of Changes
Other Study ID Numbers: ZU-AgNT-003 
Study First Received: April 17, 2007
Last Updated: December 2, 2015
Health Authority: Switzerland: Swissmedic

ClinicalTrials.gov processed this record on December 02, 2016